FDA NDC Directory · JSON-LD · Markdown

MONTELUKAST SODIUM

NDC 27241-018 · HUMAN PRESCRIPTION DRUG · TABLET, COATED

Labeler / ManufacturerAjanta Pharma USA Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203432
Dosage form / routeTABLET, COATED · ORAL
Active ingredientsMONTELUKAST SODIUM (10 mg/1)
Marketing started20150813
Package count3

External sources

Source: openFDA. Public-domain (CC0).